Sort
326,823 grants matching “clinical trial”
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)
$2,651,463Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$2,651,134Justin Ortiz · University Of Maryland Baltimore · N01 · FY2024 · AI
Mechanisms of naturally-acquired immunity to malaria
$2,650,143Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Molecular Transducers of Physical Activity Consortium - Colorado Clinical Center
$2,650,000Wendy M Kohrt · University Of Colorado Denver · U01 · FY2020 · AR
Early Biomarkers of Autism Spectrum Disorders in infants with Tuberous Sclerosis
$2,649,781Mustafa None Sahin · Boston Children'S Hospital · U01 · FY2012 · NS
GENE THERAPY FOR HEMOPHILIA AND CORONARY ARTERY DISEASE
$2,649,651Stanford University · U01 · FY2000 · HL
SPORE in Prostate Cancer
$2,649,535Baylor College Of Medicine · P50 · FY2005 · CA
Statistics Core for SWOG SDMC
$2,649,512Michael Leo Leblanc · Fred Hutchinson Cancer Center · U10 · FY2023 · CA
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,649,501David W Haas · Vanderbilt University Medical Center · UM1 · FY2024 · AI
DEVELOPMENT/TESTING OF ARTIFICIAL RETINAS FOR THE BLIND
$2,649,068Second Sight Medical Products, Inc. · R24 · FY2001 · EY
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,648,548David R Nelson · University Of Florida · UL1 · FY2011 · RR
Heart Failure Clinical Research Network Coordinating Center
$2,648,537Kevin J Anstrom · Duke University · U10 · FY2012 · HL
Pharmacogenomics and Risk of Cardiovascular Disease
$2,647,964Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U19 · FY2010 · HL
PMI Participants Preparatory/Prototyping Initiative
$2,647,514Joshua C. Denny · Vanderbilt University Medical Center · OT2 · FY2016 · OD
GENERAL CLINICAL RESEARCH CENTER
$2,647,059University Of California San Francisco · M01 · FY2000 · RR
BARI II: A TRIAL OF REVASC. & GLYCEMIC CONTROL IN NIDDM
$2,646,947Sheryl F. Kelsey · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · HL
Genetic Modifiers of Cancer Risk
$2,646,601Lisa Mirabello · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2
$2,646,599Morris Weinberger · Univ Of North Carolina Chapel Hill · KL2 · FY2018 · TR
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
$2,646,510Daniel Hal Solomon · Brigham And Women'S Hospital · U01 · FY2017 · AR
Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Humans
$2,646,398George R Uhl · National Institute On Drug Abuse · Z01 · FY2007 · DA
Data Management and Reporting Group
$2,646,316Jeff Abolafia · Rho Federal Systems Division, Inc. · UM2 · FY2019 · AI
Soweto Clinical Trials Unit
$2,645,148James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U01 · FY2008 · AI
Childhood Liver Disease Research Network Data Coordinating Center
$2,644,921John C Magee · University Of Michigan At Ann Arbor · U01 · FY2019 · DK
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery
$2,644,877Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Laboratory Center (LC): Microbicide Trials Network
$2,644,622Charlene Dezzutti · Magee-Women'S Res Inst And Foundation · UM1 · FY2014 · AI